| |
| Dr. Venkatrao H. Kulkarni, M. Pharm., Ph.D |
|
Principal & Professor, Department of Pharmacology
Contact information : SET’s College of Pharmacy, S. R. Nagar,
Dharwad-580002. |
Phones : Mob. No- 09448357804; Res: +91-836-2461554;
Off: +91-836-2448540; Fax: +91-836-2467190 |
| E-mail : kulkarnivh@rediffmail.com |
|
| |
Dr. Venkatrao H. Kulkarni completed his B. Pharm and M. Pharm from Karnatak University, Dharwad and Ph.D from Kuvempu University, Shankaraghatta, Shimoga. Presently, he is the Principal and Professor of Pharmacology and Toxicology, having 19 years of teaching and research experience. His areas of expertise include: pharmacological screening of synthetic and natural compounds for different pharmacological activities in animals.
|
| |
| Representative Publications: |
1 |
S.D. Joshi, Y. More, H.M. Vagdevi, V.P. Vaidya, G.S. Gadaginamath and V.H. Kulkarni, “Synthesis of new 4-(2,5-dimethylpyrrol-1-yl)/4-pyrrol-1-yl benzoic acid hydrazide analogs and some derived oxadiazole, triazole and pyrrole ring systems-a novel class of potential antibacterial, antifungal and antitubercular agents”, Med. Chem. Res., 22 (2013) 1073-1089. |
2 |
S.T. Shukla, V.H. Kulkarni, P.V. Habbu, K.S. Jagadeesh, B.S. Patil and D.M. Smita, “Hepatoprotective and antioxidant activities of crude fractions of endophytic fungi of Ocimum sanctum in rats”, Orien. Pharm. Exp. Med., 12 (2012) 81-91. |
3 |
S.D. Joshi, U. More, S. Dixit, G.S. Gadaginamath and V.H. Kulkarni, “In vitro antibacterial and antiviral activities of some novel 1,3,4-thidiazole derivatives” Ind. J. Hetero. Chem., 22 (2012) 109-114. |
4 |
K. Chaturvedi, K. Ganguly, M.N. Nadagouda, A.R. Kulkarni, V.H. Kulkarni, W. Rudzinski and T.M. Aminsbhavi, “Cyclodextrine based siRNA nanocarriers: A state of the art review”, Expert Opinion on Drug Delivery, 8 (2011) 1455-1468. |
5 |
S.M. Biradar, R.J. Ashwathanarayana, V.H. Kulkarni, P.V. Kulkarni, D.M. Smita and K. C. Tarak, “Protective effects of ethanolic extract of Ageranium conyzoides on experimental induced inflammatory bowel disease”, J. Pharmacol. Toxicol., 6 (2011) 664-678. |
|
|
|
